| Olivia Marie Himes, | |
|
975 Kingsview Dr, Lebanon, OH 45036-9562 | |
| (513) 228-7800 | |
| Not Available |
| Full Name | Olivia Marie Himes |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 975 Kingsview Dr, Lebanon, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003693771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | S.2303206-TRNE (Ohio) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olivia Marie Himes, 975 Kingsview Dr, Lebanon, OH 45036-9562 Ph: (513) 228-7800 | Olivia Marie Himes, 975 Kingsview Dr, Lebanon, OH 45036-9562 Ph: (513) 228-7800 |
News Archive
University of Utah researchers have discovered a naturally occurring genetic variation in mice that predisposes carriers toward developing severe, inflammatory arthritis. The finding implicates a new class of genes in arthritis progression, potentially opening doors to new treatment options.
Theravance Biopharma, Inc. and Mylan Inc. today announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases.
Falcon Physician was presented with a Gold Stevie Award in the Information Technology Department of the Year category at the 13th Annual American Business Awards in Chicago.
Medicity—the leading provider of health information exchange (HIE) solutions that empower physicians, hospitals and communities to improve care coordination, collaboration and achieve meaningful use of health information technology—today announced the U.S. Patent and Trademark Office has awarded the company Patent No. 7,653,634 for its agent-grid technology for health information exchange. This patented technology, which is at the core of Medicity's Novo Grid, has become the industry standard for seamless electronic health record (EHR) integration and community-wide health information exchange.
An individualized diet based on a person's genetics, microbiome and lifestyle is more effective in controlling blood glucose (sugar) levels than one that considers only nutritional composition of food, Mayo Clinic researchers have confirmed.
› Verified 5 days ago